Wanbury Ltd

Wanbury Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Wanbury Ltd

₹ 148 -1.69%
18 Apr - close price
wanbury.com BSE: 524212 NSE : WANBURY
About

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]

Key Points

Business Overview:[1]
WL is a pharmaceutical company with a presence in the API global market and domestic branded Formulation. It’s majorly into Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India
Formulation presence

Website BSE NSE
  • Market Cap ₹ 485 Cr.
  • Current Price ₹ 148
  • High / Low ₹ 179 / 36.6
  • Stock P/E 20.3
  • Book Value ₹ 1.01
  • Dividend Yield 0.00 %
  • ROCE 16.7 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 147 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 6.19% over past five years.
  • Promoter holding is low: 39.8%
  • Contingent liabilities of Rs.1,072 Cr.
  • Promoters have pledged 76.7% of their holding.
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -12.3%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
110 120 128 124 125 134 117 124 126 133 146 144 146
96 122 121 117 116 122 120 118 119 119 133 127 124
Operating Profit 14 -2 7 7 9 13 -3 6 6 14 13 17 21
OPM % 13% -1% 5% 6% 7% 10% -3% 5% 5% 11% 9% 12% 15%
1 1 0 0 0 77 2 1 0 -3 1 1 1
Interest 6 6 5 5 6 5 3 4 7 8 6 8 8
Depreciation 2 3 3 3 3 3 3 3 3 3 3 3 3
Profit before tax 6 -9 -1 -1 0 82 -7 -1 -3 1 5 7 10
Tax % 1% -0% -7% -11% 14% -1% 3% -25% -8% -11% 6% -2% -0%
6 -9 -1 -1 0 83 -7 -1 -3 1 5 7 10
EPS in Rs 2.36 -3.58 -0.26 -0.18 0.11 25.27 -2.21 -0.27 -1.00 0.31 1.43 2.25 3.14
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
345 414 661 250 420 432 370 391 367 392 511 500 569
336 398 620 228 387 414 438 375 344 374 475 476 503
Operating Profit 8 16 41 21 34 19 -68 16 23 18 36 23 66
OPM % 2% 4% 6% 9% 8% 4% -18% 4% 6% 5% 7% 5% 12%
18 4 -237 6 0 90 76 9 84 2 77 0 -1
Interest 33 31 48 19 32 36 31 40 33 23 21 21 29
Depreciation 9 15 23 5 9 10 10 10 10 10 11 12 13
Profit before tax -16 -25 -267 4 -7 62 -32 -25 65 -12 81 -10 23
Tax % 0% -1% -1% 28% 0% 1% 1% 1% 0% -2% -0% -1%
-16 -25 -270 3 -7 62 -32 -25 64 -13 81 -10 23
EPS in Rs -9.29 -14.66 -135.21 1.61 -3.52 26.71 -13.49 -10.48 25.79 -5.04 24.94 -3.18 7.13
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 2%
5 Years: 6%
3 Years: 11%
TTM: 14%
Compounded Profit Growth
10 Years: 5%
5 Years: 11%
3 Years: 13%
TTM: 557%
Stock Price CAGR
10 Years: 20%
5 Years: 46%
3 Years: 16%
1 Year: 290%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 17 17 20 20 20 23 24 24 25 25 33 33 33
Reserves 123 97 -186 -188 -183 -151 -183 -207 -143 -156 -30 -40 -29
395 406 389 381 373 273 224 233 164 166 74 68 113
128 156 182 182 176 265 207 235 231 253 275 241 228
Total Liabilities 663 676 404 394 386 411 271 285 277 288 351 302 345
211 198 174 164 180 186 178 172 164 167 167 167 167
CWIP 13 21 13 19 14 10 10 9 14 11 2 2 10
Investments 106 106 0 0 0 0 0 0 0 0 0 0 0
334 351 218 212 192 215 83 103 99 109 182 134 168
Total Assets 663 676 404 394 386 411 271 285 277 288 351 302 345

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-41 40 74 40 43 43 32 30 44 17 41 20
-14 -14 -7 -5 -20 -13 -1 -3 64 8 1 -9
57 -22 -75 -30 -28 -27 -33 -27 -108 -17 -29 -32
Net Cash Flow 3 3 -9 5 -5 3 -2 -0 -0 7 13 -21

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 84 74 57 144 65 71 29 41 50 32 45 50
Inventory Days 94 64 42 103 69 63 27 36 25 41 60 27
Days Payable 128 110 112 300 171 259 173 208 252 220 218 178
Cash Conversion Cycle 50 28 -13 -54 -37 -124 -117 -131 -176 -147 -112 -102
Working Capital Days -40 14 -3 -26 -44 -110 -170 -151 -186 -144 -85 -81
ROCE % 2% 1% 6% 12% 55% -1% 26% 31% 23% 46% 17%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
39.90% 39.90% 39.89% 39.89% 39.85% 39.85% 39.84% 39.84% 39.84% 39.80% 39.79% 39.79%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.18%
0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
60.09% 60.09% 60.11% 60.11% 60.15% 60.16% 60.16% 60.16% 60.16% 60.19% 60.20% 60.02%
No. of Shareholders 11,74811,58111,61911,28911,39811,55511,88811,91111,74111,63411,61613,087

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings